Ketamine Analgesia for Refractory Mucositis Pain (KARM): A prospective, double-blind, randomised, phase 2 study of ketamine for oral and pharyngeal mucositis pain
- DOI
- 10.1016/j.jpainsymman.2026.09.003
- Published
- 2026-09
- Container
- Journal of Pain and Symptom Management
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.jpainsymman.2026.09.003,
title = {Ketamine Analgesia for Refractory Mucositis Pain (KARM): A prospective, double-blind, randomised, phase 2 study of ketamine for oral and pharyngeal mucositis pain},
author = {Dr. Khunthong Peechatanan and Dr. Tim Edward Power and Ms. Jade Hudson and Dr. Shu Min Wong and Dr. Naomi T. Katz and Dr. Stefan Musolino and Professor Andrew A. Somogyi and Associate Professor Peter Poon},
year = {2026},
journal = {Journal of Pain and Symptom Management},
doi = {10.1016/j.jpainsymman.2026.09.003},
url = {https://doi.org/10.1016/j.jpainsymman.2026.09.003}
}RIS
TY - JOUR TI - Ketamine Analgesia for Refractory Mucositis Pain (KARM): A prospective, double-blind, randomised, phase 2 study of ketamine for oral and pharyngeal mucositis pain AU - Dr. Khunthong Peechatanan AU - Dr. Tim Edward Power AU - Ms. Jade Hudson AU - Dr. Shu Min Wong AU - Dr. Naomi T. Katz AU - Dr. Stefan Musolino AU - Professor Andrew A. Somogyi AU - Associate Professor Peter Poon PY - 2026 JO - Journal of Pain and Symptom Management DO - 10.1016/j.jpainsymman.2026.09.003 UR - https://doi.org/10.1016/j.jpainsymman.2026.09.003 ER -
APA
Peechatanan, D. K., Power, D. T. E., Hudson, M. J., Wong, D. S. M., Katz, D. N. T., Musolino, D. S., Somogyi, P. A. A., & Poon, A. P. P. (2026). Ketamine Analgesia for Refractory Mucositis Pain (KARM): A prospective, double-blind, randomised, phase 2 study of ketamine for oral and pharyngeal mucositis pain. Journal of Pain and Symptom Management. https://doi.org/10.1016/j.jpainsymman.2026.09.003
Source records
- crossref · retrieved 2026-09-26T03:57:16.433Z